Related Experiment Video
Updated: Feb 4, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Anti-metastatic effect of 131I-labeled Buthus martensii Karsch chlorotoxin in gliomas
Shan Wu1, Ke Ma2, Wen-Li Qiao3
1Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P.R. China.
Abstract:
The present study investigated the underlying molecular mechanism by which Buthus martensii Karsch chlorotoxin (BmK CT) inhibits the invasion and metastasis of glioma cells and the possibility of 131I‑labeled BmK CT (131I‑BmK CT) as a novel targeted agent for the treatment of glioma. The impact of BmK CT with and without 131I radiolabeling on the invasion and metastasis of glioma cells in vitro was studied. Cell viability was assessed using Cell Counting Kit‑8 and plate colony formation assays in order to confirm the cytotoxicity of BmK CT and 131I‑BmK CT at different concentrations. Transwell invasion and wound‑healing assays were conducted in order to investigate the inhibitory effects BmK CT and 131I‑BmK CT on cell migration and invasion. Furthermore, western blotting, ELISA immunofluorescence and a gelatin zymography assay were performed to evaluate changes in the protein expression levels of glioma cells following treatment with BmK CT or 131I‑BmK CT. The results indicated that BmK CT inhibits the invasion and metastasis of glioma cells via regulation of tissue inhibitor of metalloproteinase‑2 expression and that 131I‑BmK CT has the potential to be a novel targeted therapeutic drug for glioma.
Insights
Buthus martensii Karsch chlorotoxin (BmK CT) inhibits glioma cell invasion and metastasis by regulating tissue inhibitor of metalloproteinase-2. Radiolabeled 131I-BmK CT shows potential as a targeted glioma therapy.
Area of Science:
- Molecular mechanisms of cancer progression
- Neurotoxins and their therapeutic applications
- Radioisotope-based cancer therapy
Background:
- Glioma invasion and metastasis are critical challenges in treatment.
- Targeted therapies are needed to improve patient outcomes.
- Buthus martensii Karsch chlorotoxin (BmK CT) is a potential anti-cancer agent.
Purpose of the Study:
- To elucidate the molecular mechanism of BmK CT in inhibiting glioma cell invasion and metastasis.
- To evaluate 131I-labeled BmK CT (131I-BmK CT) as a potential targeted therapeutic agent for glioma.
Main Methods:
- In vitro assays including Cell Counting Kit-8, colony formation, Transwell invasion, and wound-healing assays.
- Protein expression analysis using Western blotting, ELISA, immunofluorescence, and gelatin zymography.
- Assessment of BmK CT and 131I-BmK CT effects on glioma cells.
Main Results:
- BmK CT significantly inhibited glioma cell invasion and metastasis.
- The inhibitory effect was mediated by the regulation of tissue inhibitor of metalloproteinase-2 expression.
- 131I-BmK CT demonstrated cytotoxic effects and maintained inhibitory properties in vitro.
Conclusions:
- BmK CT effectively suppresses glioma cell invasion and metastasis through modulation of tissue inhibitor of metalloproteinase-2.
- 131I-BmK CT represents a promising novel targeted therapeutic agent for glioma treatment.
More Related Videos
Related Concept Videos
Labeling Emotion
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids
Radical Anti-Markovnikov Addition to Alkenes: Overview
Radical Anti-Markovnikov Addition to Alkenes: Thermodynamics

